Response: Asthma in childhood

Abstract

148. Ellis EF: Theophylline. In Middleton E Jr, Reed CE, Ellis EF, editors: Allergy: principles and practice. St. Louis, 1978, The C. V. Mosby Co., pp. 443-9. 149. Sintek C, Hendeles L, Weinberger M: Inhibition of theophylline absorbtion by activated charcoal. J Pediatr 94:314, 1979. 150. Levy G: Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med 307:676, 1982. 151. Mason WD, Lenman RC, Amick EN, Arnold J, March L: Bioavailability of theophylline following a rectally administered concentrated aminophylline solution. J ALLERGY CLIN IMMUNOL 66:119, 1980. 152. Bernstein IL: Cromolyn sodium in the treatment of asthma: changing concepts. J ALLERGY CLIN IMMUNOL 68:247, 1981. 153. Altounyan REC: Review of the clinical activity and mode of action of sodium cromoglycate. Clin Allergy 10:481, 1980. 154. Cox JSG: Disodium cromoglycate (FLP670) (Intal): a specific inhibitor of reaginic antibody-antigen mechanism. Nature 216:1328, 1967. 155. Newth CJL, Newth CV, Turner JAP: Comparison of nebulized sodium cromoglycate and oral theophylline in controlling symptoms of chronic asthma in preschool children: a double blind study. Aust NZ J Med 12:232, 1982. 156. Morris HG, Neuman 1, Ellis EF: Plasma steroid concentrations during alternate-day treatment with prednisone. J ALLERGY CLIN IMMUNOL 54~350, 1974. 157. W) att R, Waschek J, Weinberger M, Sherman B: Effects of inhaled beclomethasone diproprionate and alternate-day prednisone in pituitary-adrenal function in children with chronic asthma. N Engl J Med 299: 1387, 1978. Asthma in childhood 539